A tough transition. [Nature. 2007] - PubMed

loading

Introduction: promoting global health through biotechnology. [Nat Biotechnol. 2004]
Introduction: promoting global health through biotechnology.
Thorsteinsdóttir H, Quach U, Martin DK, Daar AS, Singer PA. Nat Biotechnol. 2004 Dec; 22 Suppl:DC3-7.
Orphan products--pain relief for clinical development headaches. [Nat Biotechnol. 2002]
Orphan products--pain relief for clinical development headaches.
Milne CP. Nat Biotechnol. 2002 Aug; 20(8):780-4.
Doing better at doing good. [Nat Biotechnol. 2008]
Doing better at doing good.
. Nat Biotechnol. 2008 Apr; 26(4):357.
Review Orphan drug development across Europe: bottlenecks and opportunities. [Drug Discov Today. 2008]
Review Orphan drug development across Europe: bottlenecks and opportunities.
Heemstra HE, de Vrueh RL, van Weely S, Büller HA, Leufkens HG. Drug Discov Today. 2008 Aug; 13(15-16):670-6. Epub 2008 Jun 24.
Review [Hazards, tactics and constraints of evaluation of health care in low income countries]. [C R Biol. 2008]
Review [Hazards, tactics and constraints of evaluation of health care in low income countries].
Audibert M. C R Biol. 2008 Dec; 331(12):1007-15. Epub 2008 Sep 25.

Can incubators work in Africa? Acorn Technologies and the entrepreneur-centric model. [BMC Int Health Hum Rights. 2010]
Can incubators work in Africa? Acorn Technologies and the entrepreneur-centric model.
Chakma J, Masum H, Singer PA. BMC Int Health Hum Rights. 2010 Dec 13; 10 Suppl 1:S7. Epub 2010 Dec 13.
Venture funding for science-based African health innovation. [BMC Int Health Hum Rights. 2010]
Venture funding for science-based African health innovation.
Masum H, Chakma J, Simiyu K, Ronoh W, Daar AS, Singer PA. BMC Int Health Hum Rights. 2010 Dec 13; 10 Suppl 1:S12. Epub 2010 Dec 13.
The road to commercialization in Africa: lessons from developing the sickle-cell drug Niprisan. [BMC Int Health Hum Rights. 2010]
The road to commercialization in Africa: lessons from developing the sickle-cell drug Niprisan.
Perampaladas K, Masum H, Kapoor A, Shah R, Daar AS, Singer PA. BMC Int Health Hum Rights. 2010 Dec 13; 10 Suppl 1:S11. Epub 2010 Dec 13.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

A tough transition.
A tough transition.
Nature. 2007 Sep 13 ;449(7159):160-3.

PubMed
Skin barrier function and the use of emollients in dermatological nursing.
Skin barrier function and the use of emollients in dermatological nursing.
Br J Nurs. 2007 Jun 28-Jul 11 ;16(12):712, 714, 716, 718-9.

PubMed
Mortality from neurodegenerative disease and exposure to extremely low-frequency...
Mortality from neurodegenerative disease and exposure to extremely low-frequency magnetic fields: 31 years of observations on Swiss railway employees.
Neuroepidemiology. 2007 ;28(4):197-206. Epub 2007 Sep 11 .

PubMed
Flood risk mapping at European scale.
Flood risk mapping at European scale.
Water Sci Technol. 2007 ;56(4):11-7.

PubMed
Technical outcomes of sentinel-lymph-node resection and conventional axillary-ly...
Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.
Lancet Oncol. 2007 Oct ;8(10):881-8.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed